Also known as: SynaptiCure Inc., SynaptiCure
We deliver personalized medicine for neurodegenerative patients
Company is active
Event Year: 2022
Company is active
Event Year: 2022
Synapticure offers personalized virtual clinical care for patients suffering from neurodegenerative diseases, including Alzheimer's, related dementias, Parkinson's, Huntington's, and ALS. Their innovative approach places the patient and caregiver at the center of a coordinated care network. A dedicated coordinator guides patients through a comprehensive suite of multi-disciplinary resources, connecting them with local support, physical and occupational therapy, and home healthcare services. Unlike traditional clinics that provide paper referrals, Synapticure's coordinators actively assist in scheduling appointments and identifying the best physicians, durable medical equipment, clinical trials, and affordable prescriptions. Synapticure is committed to improving patient outcomes through guidance on care, insurance navigation, and access to a full range of investigational and clinical testing. Founded by patient advocates, caregivers, leading clinicians, biotech executives, and telemedicine experts, Synapticure aims to modernize neurodegenerative disease care and treatment, supported by prominent venture funds and angel investors in the remote health and life sciences sectors.
Synapticure offers personalized virtual clinical care for patients suffering from neurodegenerative diseases, including Alzheimer's, related dementias, Parkinson's, Huntington's, and ALS. Their innovative approach places the patient and caregiver at the center of a coordinated care network. A dedicated coordinator guides patients through a comprehensive suite of multi-disciplinary resources, connecting them with local support, physical and occupational therapy, and home healthcare services. Unlike traditional clinics that provide paper referrals, Synapticure's coordinators actively assist in scheduling appointments and identifying the best physicians, durable medical equipment, clinical trials, and affordable prescriptions. Synapticure is committed to improving patient outcomes through guidance on care, insurance navigation, and access to a full range of investigational and clinical testing. Founded by patient advocates, caregivers, leading clinicians, biotech executives, and telemedicine experts, Synapticure aims to modernize neurodegenerative disease care and treatment, supported by prominent venture funds and angel investors in the remote health and life sciences sectors.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2020
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2020
Healthcare
Healthcare
Healthcare -> Healthcare Services
Healthcare -> Healthcare Services
Team size: 35
Hiring: No
Team size: 35
Hiring: No